242 related articles for article (PubMed ID: 12649145)
1. Comparative response of plasma VWF in dogs to up-regulation of VWF mRNA by interleukin-11 versus Weibel-Palade body release by desmopressin (DDAVP).
Olsen EH; McCain AS; Merricks EP; Fischer TH; Dillon IM; Raymer RA; Bellinger DA; Fahs SA; Montgomery RR; Keith JC; Schaub RG; Nichols TC
Blood; 2003 Jul; 102(2):436-41. PubMed ID: 12649145
[TBL] [Abstract][Full Text] [Related]
2. A phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand disease.
Ragni MV; Jankowitz RC; Chapman HL; Merricks EP; Kloos MT; Dillow AM; Nichols TC
Haemophilia; 2008 Sep; 14(5):968-77. PubMed ID: 18680527
[TBL] [Abstract][Full Text] [Related]
3. Phase II prospective open-label trial of recombinant interleukin-11 in desmopressin-unresponsive von Willebrand disease and mild or moderate haemophilia A.
Ragni MV; Novelli EM; Murshed A; Merricks EP; Kloos MT; Nichols TC
Thromb Haemost; 2013 Feb; 109(2):248-54. PubMed ID: 23238591
[TBL] [Abstract][Full Text] [Related]
4. Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factor.
Cattaneo M; Simoni L; Gringeri A; Mannucci PM
Br J Haematol; 1994 Feb; 86(2):333-7. PubMed ID: 8199023
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 11 significantly increases plasma von Willebrand factor and factor VIII in wild type and von Willebrand disease mouse models.
Denis CV; Kwack K; Saffaripour S; Maganti S; André P; Schaub RG; Wagner DD
Blood; 2001 Jan; 97(2):465-72. PubMed ID: 11154224
[TBL] [Abstract][Full Text] [Related]
6. The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.
Johnstone IB; Crane S
Can J Vet Res; 1987 Apr; 51(2):189-93. PubMed ID: 3111674
[TBL] [Abstract][Full Text] [Related]
7. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
8. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
[TBL] [Abstract][Full Text] [Related]
9. Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.
Haberichter SL; Merricks EP; Fahs SA; Christopherson PA; Nichols TC; Montgomery RR
Blood; 2005 Jan; 105(1):145-52. PubMed ID: 15331450
[TBL] [Abstract][Full Text] [Related]
10. Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII.
López-Fernández MF; Blanco-López MJ; Castiñeira MP; Batlle J
Am J Hematol; 1992 May; 40(1):20-7. PubMed ID: 1566742
[TBL] [Abstract][Full Text] [Related]
11. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
12. Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect.
Castaman G; Federici AB; Bernardi M; Moroni B; Bertoncello K; Rodeghiero F
J Thromb Haemost; 2006 Feb; 4(2):357-60. PubMed ID: 16420565
[TBL] [Abstract][Full Text] [Related]
13. Effect of desmopressin on von Willebrand factor multimers in Doberman Pinschers with type 1 von Willebrand disease.
Callan MB; Giger U; Catalfamo JL
Am J Vet Res; 2005 May; 66(5):861-7. PubMed ID: 15938072
[TBL] [Abstract][Full Text] [Related]
14. Biological effect of desmopressin in eight patients with type 2N ('Normandy') von Willebrand disease. Collaborative Group.
Mazurier C; Gaucher C; Jorieux S; Goudemand M
Br J Haematol; 1994 Dec; 88(4):849-54. PubMed ID: 7819109
[TBL] [Abstract][Full Text] [Related]
15. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
16. Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders.
Nolan B; White B; Smith J; O'Reily C; Fitzpatrick B; Smith OP
Br J Haematol; 2000 Jun; 109(4):865-9. PubMed ID: 10929043
[TBL] [Abstract][Full Text] [Related]
17. Changes in factor VIII binding capacity of von Willebrand factor and factor VIII coagulant activity in two patients with type 2N von Willebrand disease after hemostatic treatment and during pregnancy.
Nishino M; Nishino S; Sugimoto M; Shibata M; Tsuji S; Yoshioka A
Int J Hematol; 1996 Aug; 64(2):127-34. PubMed ID: 8854570
[TBL] [Abstract][Full Text] [Related]
18. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
van Vliet HH; Kappers-Klunne MC; Leebeek FW; Michiels JJ
Thromb Haemost; 2008 Sep; 100(3):462-8. PubMed ID: 18766263
[TBL] [Abstract][Full Text] [Related]
19. Factor VIII:C increases after desmopressin in a subgroup of patients with autosomal recessive severe von Willebrand disease.
Castaman G; Lattuada A; Mannucci PM; Rodeghiero F
Br J Haematol; 1995 Jan; 89(1):147-51. PubMed ID: 7833254
[TBL] [Abstract][Full Text] [Related]
20. Storage of factor VIII variants with impaired von Willebrand factor binding in Weibel-Palade bodies in endothelial cells.
van den Biggelaar M; Bouwens EA; Voorberg J; Mertens K
PLoS One; 2011; 6(8):e24163. PubMed ID: 21909383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
